Silex Systems (SLX) H2 2025 earnings summary

Executive summary

• Achieved significant progress in commercialising SILEX laser-based uranium enrichment technology, with large-scale pilot demonstration (TRL-6) underway at GLE's Wilmington, NC facility and positive initial results reported.

• GLE acquired a 700-acre site in Paducah, KY for the planned Paducah Laser Enrichment Facility (PLEF), securing access to substantial feedstock for future operations.

• GLE selected as one of six awardees under the US DOE's LEU Enrichment Acquisition program, with potential access to up to US$900m in competitive funding.

• Construction of the first full-scale Quantum Silicon (Q-Si) production plant module advanced, targeting the emerging quantum computing market.

• Completed a $130m institutional placement to support US commercialisation and other projects, with an additional Share Purchase Plan open to shareholders.

Financial highlights

• Revenue from continuing operations was $12.2m, down from $12.9m in the prior year, mainly due to lower interest revenue.

• Net loss increased to $42.6m from $22.7m, primarily due to a $18.5m rise in Silex's share of GLE's loss, reflecting higher commercialisation spending.

• Other income rose to $6.4m, driven by increased R&D tax incentives and government grants.

• Cash holdings at year-end were $80.6m, with no corporate debt.

• Net assets decreased by 31% to $90.9m, consistent with the reported net loss.

Outlook and guidance

• GLE aims to complete the TRL-6 pilot demonstration and independent validation by end of CY2025, a key milestone for commercial deployment.

• PLEF commercial operations targeted for no later than 2030, subject to successful demonstration, regulatory approval, and market conditions.

• Ongoing engagement with US government and industry to secure further funding and support.

• Q-Si project progressing, with initial production module expected to supply the quantum computing industry.